JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)
27.09
-0.11 (-0.40%)
At close: Jan 22, 2026
SHA:603235 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Operating Revenue | 2,198 | 2,181 | 1,851 | 2,253 | 2,466 | 2,265 | Upgrade |
Other Revenue | 28 | 28 | 30.6 | 51.71 | 55.97 | 38.74 | Upgrade |
| 2,226 | 2,209 | 1,882 | 2,305 | 2,522 | 2,304 | Upgrade | |
Revenue Growth (YoY) | 10.84% | 17.35% | -18.34% | -8.63% | 9.50% | 13.76% | Upgrade |
Cost of Revenue | 1,248 | 1,288 | 1,174 | 1,450 | 1,432 | 1,054 | Upgrade |
Gross Profit | 978.41 | 920.91 | 708.11 | 854.67 | 1,090 | 1,250 | Upgrade |
Selling, General & Admin | 203.86 | 177.02 | 169.21 | 174.88 | 140.19 | 130.02 | Upgrade |
Research & Development | 102.43 | 103.82 | 111.96 | 89.46 | 58.94 | 49.36 | Upgrade |
Other Operating Expenses | 25.6 | 17.86 | 19.81 | 21.97 | 22.77 | 23.43 | Upgrade |
Operating Expenses | 330.29 | 301.92 | 299.32 | 282.46 | 228.3 | 201.83 | Upgrade |
Operating Income | 648.13 | 619 | 408.79 | 572.21 | 862.11 | 1,048 | Upgrade |
Interest Expense | -5.17 | -2.48 | -2.1 | -6.93 | -12.67 | -13.06 | Upgrade |
Interest & Investment Income | 43.29 | 64.81 | 76.54 | 22.88 | 4.34 | 13.2 | Upgrade |
Currency Exchange Gain (Loss) | 54.19 | 54.19 | 31.24 | 82.37 | -26.95 | -78.04 | Upgrade |
Other Non Operating Income (Expenses) | -29.58 | -1.25 | 0.32 | -1.74 | -1.61 | -0.94 | Upgrade |
EBT Excluding Unusual Items | 710.86 | 734.26 | 514.79 | 668.79 | 825.22 | 969.17 | Upgrade |
Gain (Loss) on Sale of Investments | 2.7 | 2.24 | - | 4.33 | -6.61 | - | Upgrade |
Gain (Loss) on Sale of Assets | -2.07 | -1.07 | -0.09 | -1.07 | -2.14 | 0.05 | Upgrade |
Asset Writedown | -9.38 | -0.61 | -0.19 | -0.86 | - | -3.29 | Upgrade |
Other Unusual Items | 36.32 | 36.95 | 50.66 | 54.57 | 56.91 | 80.8 | Upgrade |
Pretax Income | 738.43 | 771.77 | 565.17 | 725.76 | 873.37 | 1,047 | Upgrade |
Income Tax Expense | 121.39 | 120.55 | 89.32 | 103.64 | 129.49 | 159.64 | Upgrade |
Net Income | 617.04 | 651.22 | 475.85 | 622.12 | 743.89 | 887.09 | Upgrade |
Net Income to Common | 617.04 | 651.22 | 475.85 | 622.12 | 743.89 | 887.09 | Upgrade |
Net Income Growth | 10.69% | 36.85% | -23.51% | -16.37% | -16.14% | 21.90% | Upgrade |
Shares Outstanding (Basic) | 435 | 437 | 437 | 412 | 394 | 394 | Upgrade |
Shares Outstanding (Diluted) | 435 | 437 | 437 | 412 | 394 | 394 | Upgrade |
Shares Change (YoY) | -0.18% | 0.11% | 5.96% | 4.68% | -0.10% | - | Upgrade |
EPS (Basic) | 1.42 | 1.49 | 1.09 | 1.51 | 1.89 | 2.25 | Upgrade |
EPS (Diluted) | 1.42 | 1.49 | 1.09 | 1.51 | 1.89 | 2.25 | Upgrade |
EPS Growth | 10.89% | 36.70% | -27.82% | -20.11% | -16.00% | 21.82% | Upgrade |
Free Cash Flow | -235.15 | -567.3 | 193.61 | 346.11 | 603.13 | 860.63 | Upgrade |
Free Cash Flow Per Share | -0.54 | -1.30 | 0.44 | 0.84 | 1.53 | 2.18 | Upgrade |
Dividend Per Share | 0.680 | 0.680 | 0.500 | 0.710 | - | - | Upgrade |
Dividend Growth | 36.00% | 36.00% | -29.58% | - | - | - | Upgrade |
Gross Margin | 43.95% | 41.70% | 37.63% | 37.08% | 43.23% | 54.26% | Upgrade |
Operating Margin | 29.12% | 28.03% | 21.72% | 24.83% | 34.18% | 45.50% | Upgrade |
Profit Margin | 27.72% | 29.49% | 25.29% | 26.99% | 29.49% | 38.51% | Upgrade |
Free Cash Flow Margin | -10.56% | -25.69% | 10.29% | 15.02% | 23.91% | 37.36% | Upgrade |
EBITDA | 810.53 | 770.02 | 544.64 | 695.81 | 969.57 | 1,137 | Upgrade |
EBITDA Margin | 36.41% | 34.87% | 28.94% | 30.19% | 38.44% | 49.37% | Upgrade |
D&A For EBITDA | 162.4 | 151.02 | 135.85 | 123.6 | 107.46 | 89.33 | Upgrade |
EBIT | 648.13 | 619 | 408.79 | 572.21 | 862.11 | 1,048 | Upgrade |
EBIT Margin | 29.12% | 28.03% | 21.72% | 24.83% | 34.18% | 45.50% | Upgrade |
Effective Tax Rate | 16.44% | 15.62% | 15.80% | 14.28% | 14.83% | 15.25% | Upgrade |
Revenue as Reported | 2,226 | 2,209 | 1,882 | 2,305 | 2,522 | - | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.